Skip to main content
. 2021 May 7;24(6):102521. doi: 10.1016/j.isci.2021.102521

Figure 4.

Figure 4

The enriched pathways of the predicated targets of CAN and diabetes- and HF-related genes

(A) The top 20 enriched pathways of the predicted targets of CAN, which were identified using CluoGo, p < 0.05.

(B) The top 20 enriched pathways of the diabetes-related genes (from the top 200 using GeneCards) using CluoGo, p < 0.001.

(C) The top 20 enriched pathways of the HF-related genes (from the top 200 using GeneCards) using CluoGo, p < 0.001.

(D) The common pathways of (A), (B), and (C) were analyzed using Origin 2018. HF, heart failure; CAN, canagliflozin.